ISSN: 2155-9554
+44 1478 350008
Lucie Heinzerling
Associate Professor, Department of Dermatology
University Hospital of Erlangen, Germany
Lucie Heinzerling is associate professor of Dermatology and Head of the Biomarker Research Group at the University Hospital Erlangen.After her thesis in Immunology at the Charité she worked at the University Zurich (Medical Virology) and at the University hospital Zurich (Dermatology) and could thus conduct several translational phase 1 Investigator-initiated trials for melanoma and lymphoma. She also investigated gene therapy in the Angiogenesis Lab at the Ludwig Institute for Cancer Research, Melbourne. After a position as business consultant at McKinsey & Company she returned to academia at the Charité Berlin as quality manager within an EU-health network. She obtained her Master of Public Health at Harvard University and is board certified for medical tumor therapy, allergies, and quality management. She has also consulted for the World bank and for the MIT-associated Poverty Action Lab.
Her Research interests include immunotherapy of skin cancer (gene therapy, oncolytic viruses, biologics, cell therapy), adverse drug reactions and drug allergies.